ALK-Directed Therapy in Non-NSCLC Malignancies: Are We Ready?

JCO Precis Oncol. 2021 Nov:5:767-770. doi: 10.1200/PO.21.00078.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anaplastic Lymphoma Kinase / genetics
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Lung Neoplasms*

Substances

  • Anaplastic Lymphoma Kinase